Karen Mueller

Poster(s):

• Th178 - GNTI-122 Is a Stable Engineered Regulatory T Cell Therapy for Type 1 Diabetes That Is Specific, Expandable, and Efficacious in in Vivo Models
  Thursday, June 22, 2023

  7:30 AM – 7:30 PM